PHF8 overexpression in malignant cells has been reported in several cancers, including acute lymphoblastic leukemia (32), breast cancer (33), colorectal cancer (34), gastric cancer (35, 36), prostate cancer (37–40), and hepatocellular carcinoma (41). Here, PHF8 is linked to prostate carcinoma.